ArticleMethods in molecular biology (Clifton, N.J.)2027
Artificial Intelligence and Machine Learning in Mass Spectrometry-Based Proteomics and Metabolomics.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Analytical chemistry, and particularly mass spectrometry (MS), plays a central role in the molecular characterization of biological and environmental samples. These data are essential for understanding the molecular mechanisms underlying healthy aging, disease onset and progression, and the complex chemical composition of environmental systems. Over the past decades, MS has undergone unprecedented technological advancements. Current state-of-the-art instruments enable the thorough characterization of deep proteomes at the single-cell level and achieve comprehensive coverage of metabolites and proteins. Innovations such as new mass analyzers (e.g., the Astral mass analyzer) and the integration of multidimensional separation techniques (e.g., trapped/cyclic ion mobility) have significantly expanded the analytical capabilities of the instrumentation. However, the volume and complexity of the data produced by these advanced platforms pose major challenges for interpretation and integration. To address these challenges, machine learning (ML) and artificial intelligence (AI) methods are emerging as indispensable tools in analytical chemistry. These approaches, particularly deep learning, generative AI, and large language models, offer powerful solutions for analyzing, integrating, and interpreting the high-dimensional, heterogeneous datasets generated in proteomics and metabolomics research. This chapter first introduces the fundamental principles and operational mechanisms of commonly used AI/ML methods in analytical chemistry. These include regression models, decision trees, k-nearest neighbors, support vector machines, neural networks, deep learning architectures, and generative AI. The first part of the chapter also discusses key requirements for model training, including the need for sufficient sample and molecular coverage, and evaluates how data noise affects model performance and reliability. In the second part, a series of representative applications are presented, demonstrating the use of AI/ML for peptide and metabolite observability prediction, retention time and ion mobility prediction, fragment ion spectrum generation, de novo compound identification, and improvements in compound quantification and scoring of identifications. The chapter concludes with practical recommendations for applying AI/ML approaches in proteomics and metabolomics studies, and for their integration into bioinformatics pipelines to enhance data interpretation, reproducibility, and scientific discovery.
Indexed as
Identifiers
42878764What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.